The end of the formal initiative failed to soothe worries about future enforcement
Pharmaceutical Product Development mismanaged its 401(k) plan, opting for costlier investments than necessary, plaintiffs say
Over two years, the agency's initiative returned more than $139 million to investors
The brokerage will level the pay its advisers receive for the sale of some share classes, among other changes
Phillip W. Conley of West Virginia is said to have lied to investors in a Ponzi-like scheme
Other compliance experts say it’s not necessary unless the firm’s financial problems extend beyond virus stress
The agency’s emergency efforts to rescue the economy are already being viewed as uncharted territory
The insurance giant allegedly violated ERISA by failing to rein in record keeping costs
Charges against the school's retirement plan related to fees echoed similar cases brought against other universities
The Fed's signal alone was enough to loosen the cash crunch that had been squeezing global credit markets
Governor extends the deadline for regulations until 90 days after the health emergency ends
The payments present opportunities for scams, identity theft and low-tech crimes such as stealing checks from mailboxes
But an investor advocate sees the proposal as a ‘brazen effort’ to use the pandemic to promote the annuity sector
A plan participant claims the companies violated Erisa by failing to prevent a theft of more than $200,000 from her 401(k) account
The wirehouse sought to toss a large award it lost to investors who owned Puerto Rican bonds
Now customers can withdraw their claim and proceed in court or file additional claims against firm personnel
The purported scheme targeted doctors and claimed their money would be used to trade cryptocurrency using a proprietary algorithm
The CEO of the Investment Adviser Association discusses how hard it will be for advisers to meet Form CRS requirements by June 30
Experts say Finra, SEC will focus on firms' process for achieving compliance
The second government stimulus package comes as advisers are still trying to navigate the historic Cares Act
